Drug Screening Market Trends and Global Production Volumes
According to Payal Rabde, who specializes in healthcare diagnostics and life sciences markets, with 5+ years of experience in market research and industry analysis, this research shows that the global drug screening market is projected to grow from USD 7.09 billion in 2026 to USD 10.85 billion by 2035 at a 4.84% CAGR. The analysis identifies consumables, urine sample testing, cannabis/marijuana screening, and drug testing laboratories as the leading market segments. It also highlights North America's established market leadership, Asia Pacific's fastest growth trajectory, and evaluates the competitive positioning of major companies, including Abbott, Thermo Fisher Scientific, Quest Diagnostics, Roche, Danaher, and other key industry participants shaping the evolving drug screening landscape.
Last Updated : 06 August 2026
Category: Healthcare Services
Insight Code: 5332
Format: PDF / PPT / Excel